| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 4,300 | 0 | 0 | 4,300 |
| Category | Amount |
|---|---|
| NONE |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SHS First Trust | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 5709 SHS Boston Scientific Corp | 129,023 | 544,353 |
| 154 SHS Corteva Inc | 0 | 10,323 |
| 80 SHS Dow Inc | 2,682 | 1,870 |
| 469 SHS Elanco Animal Health Inc | 6,712 | 10,614 |
| 1144 SHS Eli Lilly & Co | 7,436 | 1,229,434 |
| 675 SHS Eli Lilly & Co | 612 | 725,409 |
| 10,250 SHS Eli Lilly & Co | 9,289 | 11,015,470 |
| 1,081 SHS Eli Lilly & Co | 123,829 | 1,161,729 |
| 835 SHS Eli Lilly & Co | 493,059 | 897,358 |
| 451 SHS Elanco Animal Health Inc | 6,454 | 10,206 |
| Description | Amount |
|---|---|
| Cost Basis Adjustment - Grants Paid | 21,997 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Taxes | 1,157 | 0 | 0 | 0 |